Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 9/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9539805 | 0.85 | PGR (0.41) | PGRAKR1B1CHRM1KDM4EMEN1 | |
| SCHEMBL9540047 | 0.84 | PGR (0.40) | PGRAKR1B1CHRM1KDM4EMEN1 | |
| SCHEMBL9539937 | 0.83 | CHRM1 (0.41) | PGRAKR1B1CHRM1KDM4EMEN1 | |
| SCHEMBL9540133 | 0.82 | PGR (0.39) | PGRAKR1B1CHRM1KDM4EMEN1 | |
| SCHEMBL9539997 | 0.82 | PGR (0.39) | PGRAKR1B1CHRM1ALDH1A1MAPT | |
| SCHEMBL9539032 | 0.81 | PGR (0.40) | PGRAKR1B1CHRM1MAPT | |
| SCHEMBL9539803 | 0.81 | PGR (0.38) | PGRAKR1B1CHRM1KDM4EALDH1A1 | |
| SCHEMBL9540169 | 0.81 | IDO1 (0.41) | PGRAKR1B1MEN1KMT2AIDO1 | |
| SCHEMBL9542738 | 0.81 | PGR (0.36) | PGRAKR1B1CHRM1KDM4EMEN1 | |
| SCHEMBL9539988 | 0.81 | PGR (0.36) | PGRAKR1B1CHRM1MAPTIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0530994-A1 | Quinazoline derivatives as inhibitors of HIV reverse transcriptase | MERCK & CO. INC. (US) | 1993-03-10 | — | — | EP | disclosed |
| WO-1993004047-A1 | QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO., INC. (US) | 1993-03-04 | — | — | WO | disclosed |